Radioimmunotherapy of xenografted human bladder cancer using monoclonal antibody against blood group A-related antigen

M. Y. Yeh; D. S. Yu; S. Y. Chang; C. P. Ma; S. H. Han

doi:10.1159/000472988

Radioimmunotherapy of xenografted human bladder cancer using monoclonal antibody against blood group A-related antigen

M. Y. Yeh, D. S. Yu, S. Y. Chang, C. P. Ma, S. H. Han

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

An IgG₃ murine monoclonal antibody 1G3.10 was generated against a human urinary bladder carcinoma cell line TSGH-8301. The tumor-associated antigen recognized by the monoclonal antibody is a blood group A-related substance. From fluorescence-activated cell sorter analysis, a direct cytolytic effect of tumor cells by the antibody at concentrations of more than 10 μg/ml was seen. The antibody could target iodine-131 to established subcutaneous human bladder carcinoma xenografts in BALB/c nude mice. Monoclonal antibody alone also showed some inhibitory effect on xenografted tumor growth. In this study, radiolabeled monoclonal antibody 1G3.10 presented more effective cytotoxicity than antibody alone from in vitro and in vivo experiments.

Original language	English
Pages (from-to)	386-390
Number of pages	5
Journal	European Urology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1159/000472988
Publication status	Published - Jan 1 1988
Externally published	Yes

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000472988

Cite this

@article{b115bb69d2314140950ac4f6c9e9c8a8,

title = "Radioimmunotherapy of xenografted human bladder cancer using monoclonal antibody against blood group A-related antigen",

abstract = "An IgG3 murine monoclonal antibody 1G3.10 was generated against a human urinary bladder carcinoma cell line TSGH-8301. The tumor-associated antigen recognized by the monoclonal antibody is a blood group A-related substance. From fluorescence-activated cell sorter analysis, a direct cytolytic effect of tumor cells by the antibody at concentrations of more than 10 μg/ml was seen. The antibody could target iodine-131 to established subcutaneous human bladder carcinoma xenografts in BALB/c nude mice. Monoclonal antibody alone also showed some inhibitory effect on xenografted tumor growth. In this study, radiolabeled monoclonal antibody 1G3.10 presented more effective cytotoxicity than antibody alone from in vitro and in vivo experiments.",

author = "Yeh, {M. Y.} and Yu, {D. S.} and Chang, {S. Y.} and Ma, {C. P.} and Han, {S. H.}",

year = "1988",

month = jan,

day = "1",

doi = "10.1159/000472988",

language = "English",

volume = "14",

pages = "386--390",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Radioimmunotherapy of xenografted human bladder cancer using monoclonal antibody against blood group A-related antigen

AU - Yeh, M. Y.

AU - Yu, D. S.

AU - Chang, S. Y.

AU - Ma, C. P.

AU - Han, S. H.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - An IgG3 murine monoclonal antibody 1G3.10 was generated against a human urinary bladder carcinoma cell line TSGH-8301. The tumor-associated antigen recognized by the monoclonal antibody is a blood group A-related substance. From fluorescence-activated cell sorter analysis, a direct cytolytic effect of tumor cells by the antibody at concentrations of more than 10 μg/ml was seen. The antibody could target iodine-131 to established subcutaneous human bladder carcinoma xenografts in BALB/c nude mice. Monoclonal antibody alone also showed some inhibitory effect on xenografted tumor growth. In this study, radiolabeled monoclonal antibody 1G3.10 presented more effective cytotoxicity than antibody alone from in vitro and in vivo experiments.

AB - An IgG3 murine monoclonal antibody 1G3.10 was generated against a human urinary bladder carcinoma cell line TSGH-8301. The tumor-associated antigen recognized by the monoclonal antibody is a blood group A-related substance. From fluorescence-activated cell sorter analysis, a direct cytolytic effect of tumor cells by the antibody at concentrations of more than 10 μg/ml was seen. The antibody could target iodine-131 to established subcutaneous human bladder carcinoma xenografts in BALB/c nude mice. Monoclonal antibody alone also showed some inhibitory effect on xenografted tumor growth. In this study, radiolabeled monoclonal antibody 1G3.10 presented more effective cytotoxicity than antibody alone from in vitro and in vivo experiments.

UR - http://www.scopus.com/inward/record.url?scp=0023736883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023736883&partnerID=8YFLogxK

U2 - 10.1159/000472988

DO - 10.1159/000472988

M3 - Article

C2 - 3169082

AN - SCOPUS:0023736883

SN - 0302-2838

VL - 14

SP - 386

EP - 390

JO - European Urology

JF - European Urology

IS - 5

ER -

Radioimmunotherapy of xenografted human bladder cancer using monoclonal antibody against blood group A-related antigen

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this